AviadoBio Revenue and Competitors
Estimated Revenue & Valuation
- AviadoBio's estimated annual revenue is currently $11.8M per year.
- AviadoBio's estimated revenue per employee is $155,000
Employee Data
- AviadoBio has 76 Employees.
- AviadoBio grew their employee count by 21% last year.
AviadoBio's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Scientific and Clinical Advisor | Reveal Email/Phone |
3 | Head Talent Acquisition | Reveal Email/Phone |
4 | SVP Research and Discovery | Reveal Email/Phone |
5 | VP Finance | Reveal Email/Phone |
6 | VP, Head Operations | Reveal Email/Phone |
7 | SVP, Technical Operations | Reveal Email/Phone |
8 | Head Regulatory Affairs | Reveal Email/Phone |
9 | Head Discovery | Reveal Email/Phone |
10 | VP Clinical Operations | Reveal Email/Phone |
AviadoBio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.2M | 16 | 23% | N/A | N/A |
#2 | $11.8M | 76 | 21% | N/A | N/A |
#3 | $1.8M | 23 | 35% | N/A | N/A |
#4 | $2.2M | 29 | 61% | N/A | N/A |
#5 | $1.8M | 23 | 35% | N/A | N/A |
#6 | $0.9M | 12 | 9% | N/A | N/A |
#7 | $0.1M | 1 | 0% | N/A | N/A |
#8 | $18.3M | 118 | -3% | N/A | N/A |
#9 | $0.5M | 6 | 20% | N/A | N/A |
#10 | $4.8M | 62 | 41% | N/A | N/A |
What Is AviadoBio?
At AviadoBio our mission is to transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The Company’s technology is based on pioneering research from King’s College London and the UK Dementia Research Institute.
keywords:N/AN/A
Total Funding
76
Number of Employees
$11.8M
Revenue (est)
21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12.2M | 76 | -16% | N/A |
#2 | $11M | 76 | 19% | N/A |
#3 | $11M | 76 | -27% | N/A |
#4 | $17.8M | 76 | 7% | N/A |
#5 | $19.1M | 76 | 4% | N/A |